A nutrient most people associate with energy and mood turns out to matter enormously more for anyone managing epilepsy or recovering from a traumatic brain injury. It’s rarely part of the standard neurology conversation, and it should be.
Vitamin B12 gets treated, in most general wellness content, as a mild energy booster. That framing undersells what it actually does. B12 is required to build and maintain myelin, the insulating sheath around nerve fibers that lets electrical signals travel efficiently through the nervous system. For anyone whose nervous system is already under strain, whether from seizures, a traumatic brain injury, or years of anti-seizure medication, that role stops being a minor wellness detail and becomes something worth understanding properly. This is one of several conversations worth bringing to a neurology appointment — see the fuller list in Questions to Ask Your Neurologist.
Some anti-seizure medications have been associated with lower folate or B12 levels, but the pattern differs by medication. When B12 deficiency is suspected, serum B12 is usually the starting point, with additional testing used when needed to clarify the picture.
In This Article
B12 and Myelin: Why This Matters Neurologically
B12 works as a cofactor for two specific enzymes in the body: methionine synthase and methylmalonyl-CoA mutase. The methionine synthase pathway is directly involved in synthesizing myelin, and when B12 is insufficient at the cellular level, that synthesis process starts to fail. The clinical consequences of longstanding B12 deficiency are well documented and specifically neurological: nerve damage, cognitive changes, and in more severe or prolonged cases, measurable demyelination visible on imaging.
For someone managing epilepsy or recovering from a brain injury, a nervous system that’s already working hard to function and repair itself has less margin to absorb an additional, quietly developing problem. That’s the practical reason this deserves more attention than the general “B12 for energy” framing usually gives it.
Which Medications Are Involved, and Why
A large study involving 2,730 patients with epilepsy treated with anti-seizure medications found medication-specific associations rather than one uniform effect. Carbamazepine, gabapentin, oxcarbazepine, phenytoin, primidone, and valproate were associated with lower folate levels or a greater frequency of folate values below the reference range. Phenobarbital, pregabalin, primidone, and topiramate were associated with lower B12 levels. Valproate, notably, was associated with higher B12 levels in that study. Levetiracetam and benzodiazepines were not associated with adverse folate or B12 parameters in the dataset. The practical point is that the specific medication matters; it is not accurate to treat every anti-seizure medication as having the same effect on B12 and folate.
The mechanisms involved vary somewhat by medication, but the general pattern includes interference with folate absorption and metabolism, which in turn affects the same methylation pathways B12 depends on. Long-term phenytoin use specifically has been linked in multiple studies to progressively lower B12 and folate levels the longer treatment continues, with one study finding a statistically significant drop in patients treated more than two years compared to those treated less than one.
Why a Standard B12 Test Can Miss the Problem
A standard serum B12 test measures total B12 circulating in the blood, most of which is bound to a protein called haptocorrin and isn’t actually available for cells to use. That means a serum B12 result can look normal, or even comfortably within range, while the biologically active portion your nervous system depends on is genuinely insufficient. This gap between the total number and the functional reality is exactly why relying on serum B12 alone can leave a real, developing deficiency undetected, particularly in someone whose neurological margin is already reduced.
It’s worth being honest about the limits of the more specialized tests too, rather than treating them as automatically superior. A large 2020 study comparing four different B12 markers found that for most men and for women under 50, the more sophisticated tests weren’t meaningfully better than standard serum B12 at catching deficiency. Where they clearly earned their place was in women 50 and older, where a more sensitive marker outperformed serum B12 specifically. The honest takeaway: functional testing is a genuinely useful tool in the right situation, not an automatic upgrade for everyone in every case.
The Tests That Actually Catch It
Serum or plasma B12 is typically the starting point for assessing B12 status. When the result is borderline or the clinical picture still raises concern, additional markers can help clarify whether a functional deficiency is present.
Methylmalonic acid (MMA) is considered a functional marker of B12 status. When B12 is insufficient at the cellular level, MMA tends to rise before serum B12 itself drops below the standard cutoff, which is exactly the scenario that makes it useful for catching deficiency early. MMA is primarily useful clinically as a marker of impaired B12-dependent metabolism. Researchers have proposed that disturbances in methylmalonyl-CoA metabolism and the accumulation of related metabolites may also contribute to neurological injury, but the mechanisms behind B12-related nerve and myelin damage are complex and not fully established.
Homocysteine rises when either B12 or folate is insufficient, since both nutrients are required for the same methylation cycle. An elevated result doesn’t tell you which of the two is the problem on its own, but paired with the other markers, it adds useful confirmation.
Holotranscobalamin (active B12, or holoTC) measures the fraction of circulating B12 bound to transcobalamin and available for cellular uptake. It can provide useful additional information in some diagnostic settings, but it is not universally superior to serum B12 or necessary for routine assessment.
When results are discordant or serum B12 is borderline, patterns across B12, MMA and—when appropriate—other markers can strengthen or weaken the case for deficiency, but they still need to be interpreted in clinical context.
Getting the Right Tests From Your Doctor
Most primary care and neurology visits begin with a serum B12 test when B12 deficiency is a concern. If that result is borderline, or symptoms and risk factors still make deficiency plausible, a clinician may use additional testing to clarify the picture. MMA is a particularly useful confirmatory marker, while homocysteine is less specific because folate status, kidney function, and other factors can affect it. Holotranscobalamin is another available marker in some settings, but it is not necessary as a routine test for everyone.
A more useful way to raise the issue is medication-specific rather than assuming a class-wide effect: ask whether your particular anti-seizure medication, diet, symptoms, or other risk factors make B12 or folate testing appropriate, and whether additional markers such as MMA would add useful information if the initial result is uncertain.
Shop This Category
For the crystalline, active forms of B12 and other daily essentials discussed above, my Amazon storefront reflects what I actually use.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases. See the Affiliate Disclosure for details.
FAQ
Does every anti-seizure medication lower B12?
No. The large study discussed above found medication-specific patterns rather than a class-wide effect. Some medications were associated with lower folate, some with lower B12, valproate was associated with higher B12 in that dataset, and levetiracetam and benzodiazepines were not associated with adverse folate or B12 parameters. Your specific medication matters.
Should I just start taking a B12 supplement without testing first?
Testing first gives you and your provider an actual baseline to work from, and it matters for dosing and form. It’s a reasonable conversation to have with a neurologist or primary care provider rather than a decision to make blind.
If my serum B12 came back normal, does that rule out a problem?
Not necessarily. A normal serum B12 result doesn’t rule out a functional deficiency, particularly if you’re on a medication associated with reduced levels. That’s exactly the gap MMA, homocysteine, and holotranscobalamin are designed to catch.
Is this only relevant for people with anemia symptoms?
No. Neurological symptoms from B12 deficiency, including nerve changes and cognitive effects, can appear well before anemia shows up on a basic blood panel. Waiting for anemia to prompt testing misses the window where catching this early matters most.
B12 isn’t just an “energy vitamin.” Deficiency can affect the nervous system, and medication, diet, absorption, symptoms, and other individual risk factors can help determine when B12 status is worth discussing or testing.
This is one piece of the fuller picture worth discussing with your neurologist alongside bone density, hormonal health, and SUDEP risk. I’ve written a full breakdown of all four in Questions to Ask Your Neurologist, and the medication-specific mechanisms behind bone and hormonal effects in What Long-Term Anti-Seizure Medications Do to Your Bones and Hormones.
Want the complete Epilepsy Support Guide?
Seizure types and triggers, medication management, SUDEP awareness, seizure first aid, and how to find quality medical care, all in one free guide.
Related Reading
Questions to Ask Your Neurologist — The fuller list of conversations worth having, including this one.
What Long-Term Anti-Seizure Medications Do to Your Bones and Hormones — The related bone density and hormonal effects worth monitoring alongside B12.
Supplements I’ve Tried: What Stayed, What Went, and Why — My own honest account, including the reasoning behind my B12 form specifically.
Understanding Epilepsy — Start here for the broader epilepsy support, safety, and education hub.
Sources & Further Reading
Linnebank et al. — Antiepileptic Drugs Interact With Folate and Vitamin B12 Serum Levels — Annals of Neurology, the primary large-population study on this topic.
Long-Term Phenytoin and Serum Folate/B12 Levels — Scientific Reports, on the medication-duration relationship.
Diagnostic Accuracy of Holotranscobalamin, B12, MMA, and Homocysteine — Disease Markers, comparing the four testing approaches.
Holotranscobalamin and Methylmalonic Acid as Diagnostic Tools for B12 Deficiency — Overview of how the functional markers relate to each other.
Disclaimer
Content on Real David Julian is provided for educational and informational purposes and may include research-based discussion, personal experience, and opinion. It is not medical advice and is not a substitute for individualized care from a qualified healthcare professional. Always discuss your specific health needs, diagnoses, medications, supplements, treatments, or major health decisions with an appropriate healthcare professional. See the full Disclaimer for additional information.